G Kuchukhidze
Overview
Explore the profile of G Kuchukhidze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bosque Varela P, Machegger L, Steinbacher J, Oellerer A, Pfaff J, McCoy M, et al.
Epilepsy Behav
. 2024 Nov;
161:110081.
PMID: 39489995
Background: Status epilepticus (SE) is a severe neurological condition that might lead to long-term consequences such as neuronal death. This study investigated whether SE leads to brain volume loss by...
2.
Matteelli A, Mkrtchyan Z, Masini T, Hovhannesyan A, Kuchukhidze G, Ahmedov S, et al.
IJTLD Open
. 2024 Aug;
1(8):349-354.
PMID: 39131590
Background: TB preventive treatment (TPT) is the primary available healthcare intervention to reduce the risk of progression from TB infection to TB disease. The WHO Regional Office for Europe established...
3.
Rainer L, Granbichler C, Kobulashvili T, Kuchukhidze G, Rauscher C, Renz N, et al.
Epilepsy Res
. 2022 Apr;
182:106917.
PMID: 35390702
Objective: Epilepsies are severe chronic neurological diseases that impair several domains in life and are often accompanied by various somatic and psychiatric comorbidities. Associations between epilepsy and its comorbidities remain...
4.
Adamashvili N, Baliashvili D, Kuchukhidze G, Salindri A, Kempker R, Blumberg H, et al.
Int J Tuberc Lung Dis
. 2022 Mar;
26(4):326-333.
PMID: 35351237
Loss to follow-up (LTFU) is common among patients with drug-resistant TB (DR-TB) receiving second-line TB treatment; however, little is known about outcomes after LTFU, including mortality. To determine rates of...
5.
Rohracher A, Kalss G, Kuchukhidze G, Neuray C, Leitinger M, Hofler J, et al.
Expert Opin Pharmacother
. 2020 Oct;
22(5):621-634.
PMID: 33111598
: The number of elderly patients with epilepsy is growing in resource rich countries due to demographic changes and increased longevity. Management in these patients is challenging as underlying etiology,...
6.
Baliashvili D, Kempker R, Blumberg H, Kuchukhidze G, Merabishvili T, Aslanikashvili A, et al.
Public Health Action
. 2018 Oct;
8(3):110-117.
PMID: 30271726
Identification and screening of contacts of patients with active tuberculosis (TB) is infrequent in low- and middle-income countries. To estimate the incidence, prevalence and risk factors of latent tuberculous infection...
7.
Granbichler C, Oberaigner W, Kuchukhidze G, Ndayisaba J, Ndayisaba A, Taylor A, et al.
Eur J Neurol
. 2017 Feb;
24(5):667-672.
PMID: 28239917
Background And Purpose: Data on mortality in patients with epilepsy have been available since the 1800s. They consistently show a 2-3-fold increase compared to the general population. Despite major advances...
8.
Schmid E, Kuchukhidze G, Kirschner M, Leitinger M, Hofler J, Rohracher A, et al.
Acta Neurol Scand
. 2016 Jul;
135(4):449-453.
PMID: 27444636
Objectives: There are clinical situations where it might be appropriate to switch patients from immediate-release oxcarbazepine (OXC) to eslicarbazepine acetate (ESL). We investigated the effects of transitioning patients overnight from...
9.
Kuchukhidze G, Kumar A, de Colombani P, Khogali M, Nanava U, Blumberg H, et al.
Public Health Action
. 2015 Sep;
4(Suppl 2):S41-6.
PMID: 26393097
Setting: Georgia, a country with a high-burden of multi-drug-resistant tuberculosis (MDR-TB). Objective: To determine the proportion of loss to follow-up (LFU) among MDR-TB patients treated nationwide from 2009 to 2011,...
10.
Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al.
Epilepsy Behav
. 2015 Jun;
49:158-63.
PMID: 26092326
Background: Salzburg Consensus Criteria for diagnosis of Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus in Salzburg (2013). Methods: We retrospectively analyzed the EEGs...